Catalyst
Slingshot members are tracking this event:
Tesaro (TSRO) Plans to Launch Niraparib in U.S in 1H 2017 for Ovarian Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TSRO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 19, 2017
Occurred Source:
http://ir.tesarobio.com/releasedetail.cfm?ReleaseID=1021948
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Niraparib, Ovarian Cancer, Fda, Commercial Launch, Treatment-resistant Ovarian Cancer
